Romania, May 13 -- The European Investment Bank (EIB) will advise Antibiotice SA, the largest pharmaceutical company with majority Romanian capital, on strengthening its corporate governance to support future growth. Under a new advisory services agreement, the EIB will work with Antibiotice to align its risk-management framework and business operations with international best practice in the pharmaceutical sector.The advisory agreement is a continuation of the partnership with the EIB and aims to strengthen Antibiotice's capacity to attract financing, support future investments and reinforce long-term competitiveness in a rapidly evolving healthcare market. The EIB support will also reinforce transparency, operational oversight and long-te...